About
Incubate

Our Mission

Overview

Incubate is a 501(c)(4) organization of venture capital firms representing the patient, corporate, and investment communities. Our primary aim is to educate policymakers on the role of venture capital in bringing promising treatments to patients in need.

Mission

We help ensure patients continue to benefit from the unrelenting innovation spurred by venture capital investment in life sciences and protected by America’s intellectual property system.

Our Priorities

1

Foster innovation

Help ensure a level global playing field for investment and promote policies that empower life science innovators to build and grow in the United States.

Why It Matters

For America to remain the leader in medical innovation, its business, investment, and policy ecosystems must welcome and support life science innovators from start-ups to major firms.

2

Safeguard advancements

Strengthen and protect U.S. intellectual property provisions by promoting patent and regulatory systems that encourage life sciences innovation.

Why It Matters

Investment in life science is risky: 9 out of 10 initial treatments are ineffective or don’t recoup their development costs. Protecting the American intellectual property system preserves incentives for the development of new treatments and ensures that the revenue from successful treatments can subsidize continued innovation.

3

Amplify the results

Spotlight the venture capital-driven breakthroughs that are transforming medicine for patients and health professionals around the globe.

Why It Matters

Amidst the nuanced discussions around healthcare costs in this country, policymakers, providers, and patients all deserve a complete understanding of the factors that contribute to successful development of effective treatments.

Resources

Get valuable information on policy, venture capital, and the life sciences innovation ecosystem.

Our People

Incubate Board Members

Lindsay Androski
Lindsay Androski

President

Janis Naeve
Janis Naeve

Treasurer

Advisory Board

Lindsay Androski
Lindsay Androski
M.B.A, J.D.

President and CEO,
Roivant Foundation
Roivant Sciences

Christine Brennan
Christine Brennan

Managing Director,
Vertex Venture HC

John Conrad
John Conrad

President & CEO,
Illinois Biotechnology Innovation Organization (iBIO)

Brian Darmody
Brian Darmody

CEO,
Association of University Research Parks (AURP)

Barbara Dalton
Barbara Dalton
Ph.D

Vice President, WWBD and Senior Managing Partner,
Pfizer Ventures

Bart Forsyth
Bart Forsyth
JD

Vice President,
Federal Advocacy
PhRMA

Gaurav Gupta
Gaurav Gupta
M.D., M.S.

Founder and Managing Partner,
Ascendant BioCapital

Orin Herskowitz
Orin Herskowitz

Executive Director, Columbia Technology Ventures

Adam Houghton
Adam Houghton
Ph.D., M.B.A.

Chief Business Officer,
Upstream Bio

Chris Israel
Chris Israel
M.B.A

Senior Partner,
American Continental Group

Peter Kolchinsky
Peter Kolchinsky
Ph.D.

Managing Partner,
RA Capital Management;
Author of The Biotech Social Contract series on Medium

Gary Lauder
Gary Lauder
M.B.A.

Managing Director,
Lauder Partners

Erin Mistry
Erin Mistry

Senior Vice President,
Payer Strategy
Cormedix

Amy Millman
Amy Millman
M.P.A.

President and Co-Founder,
Springboard Enterprises

Janis Naeve
Janis Naeve
Ph.D.

Partner
Cota Capital

Imran Nasrullah
Imran Nasrullah
M.S. J.D

VP & US Head,
Collaborate2Cure Hub, Bayer

Sara Nayeem
Sara Nayeem
M.D.

Partner,
Avoro Ventures

Emily Roberts
Emily Roberts

Director,
Issue Advocacy
Genentech

Nancy Sullivan
Nancy Sullivan

CEO,
Illinois Ventures

Karla Talanian
Karla Talanian
M.S., M.B.A.

Senior Director of Life Sciences Apprenticeships,
MassBio

Matt Tremblay
Matt Tremblay

Chief Operating Officer,
Scripps Research

Rose Wang
Rose Wang
M.B.A.

Executive Advisor,
AIM-HI Accelerator Fund

Jonathan Weinberger
Jonathan Weinberger
J.D., M.A.

Chief Advocate,
Global Transportation Technology Policy

Peter Young
Peter Young
M.B.A.

Life Science Executive & Venture Partner,
Pappas Capital

Our Team

John Stanford
John Stanford

Executive Director

Ashlyn Roberts
Ashlyn Roberts

Senior Manager

Jay Perron
Jay Perron

Director, Government Relations

Olivia Lucanie
Olivia Lucanie

Senior Associate